GLP-1 Weight Loss Medication - Search News

News

GLP-1, Eli Lilly and weight loss

CBS News on MSN · 7h

GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss.

Eli Lilly's new GLP-1 weight loss pill showed success in clinical trial

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, Wegovy, Mounjaro and Zepbound, a clinical trial shows.

Fox News on MSN · 7h

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

36mon MSN

Blue Cross Blue Shield of Massachusetts will stop covering popular drugs for weight loss. Here's why.

Weight loss drugs have skyrocketed in price and popularity and now they are being blamed for crippling budgets in the public ...

3d

Study identifies 3 strategies to minimize muscle loss from GLP-1 weight loss drugs

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Becker's Hospital Review3d

Pfizer discontinues GLP-1 weight loss drug

Pfizer has ceased development of its oral GLP-1 weight loss drug candidate, danuglipron, after a study participant ...

ConsumerAffairs2d

GLP-1 for weight loss

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

1d

Weight Loss Drugs Are Changing Diets – And Shaking Up the Food Industry

People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results